Optimal glycaemic control and a low rate of micro and macrovascular complications in patients with HNF1A-MODY treated in a dedicated tertiary referral centre

Abstract

MODY refers to Maturity Onset Diabetes of the Young, an autosomal dominant form of diabetes affecting beta-cell function. Mutations in multiple genes are known to cause MODY. The most common MODY subtype in European countries, including Ireland, is